CLINICAL_TRIALS
trial_result
· 2020-08-11
Clinical Trial Update: Augmenting Flortaucipir Dosimetry Estimates [Phase 1]
Summary
Phase 1 clinical trial update focusing on dosimetry estimates for flortaucipir in Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-08-11